Publications by authors named "David A Eichenbaum"

Claim this Profile
R
Reply to Comment on Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
David A Eichenbaum, Nancy Holekamp, Arshad M Khanani, Dante Pieramici, Vrinda Hershberger

Am J Ophthalmol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
David A Eichenbaum, Nancy Holekamp, Arshad M Khanani, Dante Pieramici, Vrinda Hershberger

Am J Ophthalmol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RWC Update: Intraocular Inflammation and Retinal Pharmacotherapy; Giant Retinal Tear; ILM Peeling in Myopic Macular Schisis.
Ashish Sharma, Lihteh Wu, Steven Bloom, Paulo Stanga, David A Eichenbaum

Ophthalmic Surg Lasers Imaging Retina· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab: Summary of Cases during Clinical Trial Development.
David A Eichenbaum, William R Freeman, Margaret A Chang, Logan Brooks, Nauman Chaudhry

Ophthalmol Retina· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of 8 mg aflibercept in neovascular AMD: a case series.
Deepak Sambhara, Priya Vakharia, David A Eichenbaum

BMJ Open Ophthalmol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screen Failures in Clinical Trials in Retina.
Nasiq Hasan, Kunaal Mehrotra, Carl J Danzig, David A Eichenbaum, Amy Ewald

Ophthalmol Retina· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration.
Sunil Patel, Philip P Storey, Mark R Barakat, Vrinda Hershberger, William Z Bridges, David A Eichenbaum

Ophthalmol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.
Rishi P Singh, Mark R Barakat, Michael S Ip, Charles C Wykoff, David A Eichenbaum

JAMA Ophthalmol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Arshad M Khanani, Sunil S Patel, Giovanni Staurenghi, Ramin Tadayoni, Carl J Danzig, David A Eichenbaum

Lancet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars in the Treatment of Retinal Disease in the United States.
Priya S Vakharia, David A Eichenbaum, Caroline R Baumal

Ophthalmic Surg Lasers Imaging Retina· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral Hypotony Maculopathy Associated With Ipilimumab and Nivolumab Therapy Unresponsive to Corticosteroid Treatment.
Abrahim A Ahmed, Farhan E Hiya, David A Eichenbaum

Ophthalmic Surg Lasers Imaging Retina· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus.
Anton M Kolomeyer, David A Eichenbaum, Daniel F Kiernan, Ivan J Suñer, Seenu M Hariprasad

Ophthalmic Surg Lasers Imaging Retina· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII).
Rui Wang, Cynthia K McClard, Stephen Laswell, Raziyeh Mahmoudzadeh, Mirataollah Salabati, David A Eichenbaum

BMJ Open Ophthalmol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab port delivery system: a clinical perspective.
David A Eichenbaum, Abrahim Ahmed, Farhan Hiya

BMJ Open Ophthalmol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Charles C Wykoff, Francis Abreu, Anthony P Adamis, Karen Basu, David A Eichenbaum

Lancet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiopoietins as Potential Targets in Management of Retinal Disease.
Arshad M Khanani, Matthew W Russell, Aamir A Aziz, Carl J Danzig, Christina Y Weng, David A Eichenbaum

Clin Ophthalmol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration.
Ana Bety Enríquez, Caroline R Baumal, Ashley M Crane, Andre J Witkin, David R Lally, David A Eichenbaum

JAMA Ophthalmol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor: Evolving Guidelines for Intracameral Injection.
David A Eichenbaum, Jeffrey M Liebmann, Keith Barton, Robert N Weinreb, Preeya K Gupta

J Glaucoma· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration.
Allen C Ho, Jeffrey S Heier, Nancy M Holekamp, Richard A Garfinkel, Byron Ladd, David A Eichenbaum

J Clin Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Guidelines for Intracameral Injection.
Jeffrey M Liebmann, Keith Barton, Robert N Weinreb, David A Eichenbaum, Preeya K Gupta

J Glaucoma· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review.
Saira Khanna, Rahul Komati, David A Eichenbaum, Ishani Hariprasad, Thomas A Ciulla

BMJ Open Ophthalmol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema.
Sidney A Schechet, Olufemi E Adams, David A Eichenbaum, Seenu M Hariprasad

BMJ Open Ophthalmol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monthly Versus Treat-and-Extend Ranibizumab for Diabetic Macular Edema: A Prospective, Randomized Trial.
David A Eichenbaum, Emily Duerr, Hershel R Patel, Scott M Pollack

Ophthalmic Surg Lasers Imaging Retina· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy.
Charles C Wykoff, David A Eichenbaum, Daniel B Roth, Lauren Hill, Anne E Fung

Ophthalmol Retina· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When and How to Incorporate Steroids for Persistent Diabetic Macular Edema: A Discussion of Real-World Treatment Optimization Strategies.
David A Eichenbaum, Carlos Buznego, Christina Y Weng, Dilsher S Dhoot, Charles C Wykoff

Ophthalmic Surg Lasers Imaging Retina· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis